Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Tremblay

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Annals of the American Thoracic Society|March 23, 2026
Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysisKum Ju Chae, Hyunsook Hong, Claire C Cutting, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Annals of the American Thoracic Society|March 23, 2026
Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysisKum Ju Chae, Hyunsook Hong, Claire C Cutting, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
Pageof 14